Active substance
Results for the substance elosulfase alfa
1 result
About this active substance
Elosulfase alfa is a medication used for the treatment of mucopolysaccharidosis type IV (Morquio A syndrome), a rare genetic disorder caused by a deficiency of the enzyme N-acetylgalactosamine-6-sulfatase. This enzyme is essential for breaking down certain complex molecules in the body.
The medication is administered via intravenous infusion and helps reduce the accumulation of glycosaminoglycans in cells, which can improve mobility and respiratory function in patients. Treatment must be carried out under the supervision of a specialist experienced in rare metabolic diseases.
Common side effects include fever, chills, headache, and infusion site reactions. In rare cases, severe allergic reactions may occur, and patients should be closely monitored during administration.
Elosulfase alfa is an important therapeutic option for patients with Morquio A syndrome, helping to improve their quality of life and slow disease progression.
The medication is administered via intravenous infusion and helps reduce the accumulation of glycosaminoglycans in cells, which can improve mobility and respiratory function in patients. Treatment must be carried out under the supervision of a specialist experienced in rare metabolic diseases.
Common side effects include fever, chills, headache, and infusion site reactions. In rare cases, severe allergic reactions may occur, and patients should be closely monitored during administration.
Elosulfase alfa is an important therapeutic option for patients with Morquio A syndrome, helping to improve their quality of life and slow disease progression.